Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Microglia
100%
Patient Tumor
100%
Glioblastoma
100%
Patient-derived Xenograft
100%
Cell-like
100%
Tumor-derived
100%
Phenotypic States
100%
Tumor Microenvironment
60%
Myeloid Cells
53%
Tumor
20%
Temozolomide
20%
Tumor Cells
13%
Cell Population
13%
Glioma Patients
13%
Major Components
13%
Orthotopic Xenograft Model
13%
Gene Expression Programming
13%
Host Cell
6%
Immune System
6%
Glioma Model
6%
Brain Tumor
6%
Transcriptome
6%
Astrocytic
6%
Normal Brain
6%
Phenotypic Change
6%
Flow Cytometry Assay
6%
Functional Level
6%
Human Glioblastoma
6%
Antitumoral
6%
Antigen Presentation
6%
Tumoral
6%
Functional Assay
6%
Phagocytosis
6%
Blood-brain Barrier Disruption
6%
Tumor Phenotype
6%
Molecular Changes
6%
Endothelial Markers
6%
Immunotherapeutic Approaches
6%
Resident Microglia
6%
Multiparameter Flow Cytometry
6%
Intratumoral Heterogeneity
6%
Tumor-normal
6%
Transcriptional Adaptation
6%
Heterogeneous Tumors
6%
Immunohistochemical Tests
6%
Antineoplastic Drugs
6%
Transcriptomic Adaptation
6%
Phenotypic Adaptation
6%
Transcriptomic Plasticity
6%
Tumor-immune Interaction
6%
GL261 Glioma
6%
Spatial Transcriptomics
6%
Tumor Niche
6%
Single-cell RNA Sequencing (scRNA-seq)
6%
Evade
6%
Microglial States
6%
Glioblastoma Tumor
6%
Immune-suppressive
6%
Immune Cell Populations
6%
Cell Identity
6%
Environmental Heterogeneity
6%
Supportive Role
6%
Immunology and Microbiology
Microglia
100%
Xenograft
100%
Dendritic Cell
100%
Myeloid
100%
Phagocyte
100%
Transcriptomics
44%
Cell Population
33%
Tumor Cell
22%
Gene Expression
22%
RNA Sequence
11%
Immunocompetent Cell
11%
Blood Brain Barrier
11%
Host Cell
11%
Phagocytosis
11%
Antigen Presentation
11%
Immune System
11%
Neuroscience
Myeloid
100%
Microglia
100%
Transcriptomics
44%
Temozolomide
33%
Gene Expression
22%
Glioma
11%
Phagocytosis
11%
Blood Brain Barrier
11%
RNA Sequence
11%
Immunohistochemistry
11%
Antigen
11%
Intracranial Tumor
11%
Flow Cytometry
11%